Trial: 202111042

Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia – Chronic Phase (CML-CP)

Phase

II

Principal Investigator

Hayashi, Robert

Disease Site

Myeloid and Monocytic Leukemia

Learn more about this study at: clinicaltrials.gov